194 results on '"Hazan-Halevy, Inbal"'
Search Results
2. Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
3. Unlocking the therapeutic potential of locked nucleic acids through lipid nanoparticle delivery
4. Extrahepatic delivery of RNA to immune cells
5. Contributors
6. STAT3-Activated GM-CSFRα Translocates to the Nucleus and Protects CLL Cells from Apoptosis
7. P1355: DELIVERY OF THERAPEUTIC RNA TO THE BONE MARROW IN MULTIPLE MYELOMA USING CD38-TARGETED LIPID NANOPARTICLES
8. A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery (Adv. Sci. 19/2023)
9. Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles (Adv. Sci. 21/2023)
10. mRNA Vaccines: Using Tiny Particles to Fight Viruses
11. Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells
12. Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles
13. Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines
14. A modular platform for targeted RNAi therapeutics
15. A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium
16. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
17. Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes
18. Targeting Signal Transducer and Activator of Transcription (STAT) for Anticancer Therapy
19. An Effective mRNA-LNP Vaccine Against the Lethal Plague Bacterium
20. Therapeutic Gene Silencing of CKAP5 leads to lethality in genetically unstable cancer cells.
21. Personalized medicine in CLL: Current status and future perspectives
22. Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer (Adv. Mater. 13/2022)
23. Activation of Cytosolic Phospholipase A2 by Opsonized Zymosan in Human Neutrophils Requires Both ERK and p38 Map-Kinase
24. STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells
25. Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo
26. Increased CD39 expression on CD4+ T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia
27. The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells
28. Kit inhibitor APcK110 extends survival in an AML xenograft mouse model
29. The Effects of Natural Antioxidants from Tomato Extract in Treated but Uncontrolled Hypertensive Patients
30. Targeting Signal Transducer and Activator of Transcription (STAT) for Anticancer Therapy
31. Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
32. RNA Delivery: A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes (Adv. Mater. 12/2020)
33. A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
34. Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles
35. Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes
36. Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
37. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
38. Metabolism pathways in chronic lymphocytic leukemia
39. The Cytokine Midkine and its Receptor RPTPζ Regulate B Cell Survival in a Pathway Induced by CD741
40. Signal Transducer and Activator of Transcription (STAT)-3 Activates Nuclear Factor (NF)-κB in Chronic Lymphocytic Leukemia Cells
41. STAT3-induced GM-CSFRα Protects Chronic Lymphocytic Leukemia (CLL) Cells From Apoptosis
42. Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells
43. STAT3-Activated GM-CSFRα Shuttles To The Nucleus and Protects CLL Cells From Apoptosis
44. CD84 is a survival receptor for chronic lymphocytic leukemia cells (P2044)
45. Divergence in CD19-Mediated Signaling Unfolds Intraclonal Diversity in Chronic Lymphocytic Leukemia, Which Correlates with Disease Progression
46. Metabolism pathways in chronic lymphocytic leukemia.
47. Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia
48. The Cytokine Midkine and Its Receptor RPTPζ Regulate B Cell Survival in a Pathway Induced by CD74
49. Signal Transducer and Activator of Transcription (STAT)-3 Induces Granulocyte/Macrophage Colony-Stimulating Factor (GM-CSF) Receptor-α Expression in Chronic Lymphocytic Leukemia (CLL) Cells,
50. 2.7 Intra-Clonal Diversity Identified by CD19-Mediated Signaling Correlates with Disease Progression in CLL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.